OUT OF OFFICE: Your essential round-up of the latest business news
hVIVO, a subsidiary of Dublin-listed pharmaceutical company Open Orphan, has reached a deal with the UK government to develop a Covid-19 human challenge study model. Test subjects could be exposed to the coronavirus in controlled settings as early as January 2021 in an effort to speed up the development of a vaccine. A number of young and healthy participants, aged 18 to 30, will be given a vaccine candidate previously assessed in earlier clinical trials.
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
24% decline in gross new lending to Irish SMEs in 2021, Central Bank says
New data released by the Irish financial regulator indicated that gross new lending to SMEs experienced its sharpest decline in years during the Covid-19 pandemic
Polish start-up raised €12m to bring revenue financing to Ireland
Booste says it can provide early-stage start-ups with revenue-based financing options within 24 hours of application
PUP should be cut faster to get workers back, Isme says
Group says lack of state guidance on companies’ right to staff vaccination status puts employers in an impossible position